Running Oak Capital’s Boston Scientific BSX Stock Holding History

Running Oak Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.27M	Buy	+193,882	New	+$10.5M	1.41%	49
2025 Q3	–	Sell	-1,986	Closed	-$213K	–	56
2025 Q2	$213K	Sell	1,986 -268	-12%	-$27.1K	0.02%	56
2025 Q1	$227K	Sell	2,254 -169,085	-99%	-$17M	0.03%	56
2024 Q4	$15.3M	Buy	171,339 +8,018	+5%	+$706K	2%	6
2024 Q3	$13.7M	Buy	163,321 +3,653	+2%	+$288K	1.85%	16
2024 Q2	$12.3M	Sell	159,668 -7,841	-5%	-$574K	1.91%	7
2024 Q1	$11.5M	Buy	167,509 +13,634	+9%	+$877K	1.84%	20
2023 Q4	$8.9M	Buy	153,875 +23,091	+18%	+$1.23M	1.75%	36
2023 Q3	$6.91M	Buy	130,784 +1,717	+1%	+$90K	1.77%	32
2023 Q2	$6.98M	Buy	+129,067	New	+$6.74M	1.71%	40

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Running Oak Capital's BSX Position: Q2 2026 in Review

Running Oak Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 193,882 shares worth $8.27M. The stake represents 1.41% of the portfolio and ranks #49 among its holdings. This is a return to the name: Running Oak Capital previously reported a position in BSX as recently as Q2 2025.

Running Oak Capital first reported a position in BSX in Q2 2023 and has held it in 10 quarters since. The position peaked at $15.3M in Q4 2024. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Running Oak Capital held 193,882 shares of Boston Scientific worth $8.27M as of Q2 2026.
Boston Scientific was a new Running Oak Capital position in Q2 2026.
Boston Scientific made up 1.41% of Running Oak Capital's portfolio in Q2 2026, its #49 holding.
Running Oak Capital first reported a position in Boston Scientific in Q2 2023 and has held it in 10 quarters since.
Running Oak Capital's Boston Scientific position peaked at $15.3M in Q4 2024.
1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Running Oak Capital's 13F filing for Q2 2026, filed 30 Jul 2026.